Dose Escalation Study of Epirubicin and Docetaxel in Patients with Advanced or Recurrent Breast Cancer
Ichiro Ichinose(Fukuoka University), Kazuo Tamura(Kindai University), Tadashi Ikeda(Keio University), Shoshu Mitsuyama(Kitakyushu Municipal Medical Center), Emi Ishikawa(Kyowa Chemical Industry (Japan)), N Horikoshi(Japanese Foundation For Cancer Research), Yuzo Hamada(Hiroshima University), Sunao Kobayashi(Jikei University School of Medicine)
Cited by 6
Related Papers
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the Clinical Practice of Hereditary Colorectal Cancer
|International Journal of Clinical Oncology|2021|157
Cross‐sectional analysis of germline <i>BRCA</i>1 and <i>BRCA</i>2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer
|Cancer Science|2008|105
Hepatic Arterial Infusion Chemotherapy Using Low-Dose 5-Fluorouracil and Cisplatin for Advanced Hepatocellular Carcinoma
|Oncology|2010|102
Non-Invasive Evaluation of Hepatic Fibrosis for Type C Chronic Hepatitis
|Intervirology|2010|79